title: Demonstrating a multi-drug resistant Mycobacterium tuberculosis amplification microarray.
abstract: Simplifying microarray workflow is a necessary first step for creating MDR-TB microarray-based diagnostics that can be routinely used in lower-resource environments. An amplification microarray combines asymmetric PCR amplification, target size selection, target labeling, and microarray hybridization within a single solution and into a single microfluidic chamber. A batch processing method is demonstrated with a 9-plex asymmetric master mix and low-density gel element microarray for genotyping multi-drug resistant Mycobacterium tuberculosis (MDR-TB). The protocol described here can be completed in 6 hr and provide correct genotyping with at least 1,000 cell equivalents of genomic DNA. Incorporating on-chip wash steps is feasible, which will result in an entirely closed amplicon method and system. The extent of multiplexing with an amplification microarray is ultimately constrained by the number of primer pairs that can be combined into a single master mix and still achieve desired sensitivity and specificity performance metrics, rather than the number of probes that are immobilized on the array. Likewise, the total analysis time can be shortened or lengthened depending on the specific intended use, research question, and desired limits of detection. Nevertheless, the general approach significantly streamlines microarray workflow for the end user by reducing the number of manually intensive and time-consuming processing steps, and provides a simplified biochemical and microfluidic path for translating microarray-based diagnostics into routine clinical practice.
authors.affiliation: Akonni Biosystems, Inc.
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Linger
authors.affiliation: Akonni Biosystems, Inc.
authors.forename: Alexander
authors.initials: A
authors.lastname: Kukhtin
authors.affiliation: Akonni Biosystems, Inc.
authors.forename: Julia
authors.initials: J
authors.lastname: Golova
authors.affiliation: Akonni Biosystems, Inc.
authors.forename: Alexander
authors.initials: A
authors.lastname: Perov
authors.affiliation: Akonni Biosystems, Inc.
authors.forename: Peter
authors.initials: P
authors.lastname: Qu
authors.affiliation: Akonni Biosystems, Inc.
authors.forename: Christopher
authors.initials: C
authors.lastname: Knickerbocker
authors.affiliation: Akonni Biosystems, Inc.
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Cooney
authors.affiliation: Akonni Biosystems, Inc.; DChandler@akonni.com.
authors.forename: Darrell P
authors.initials: DP
authors.lastname: Chandler
mesh_terms: D024901:Drug Resistance, Multiple, Bacterial; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics*; D016133:Polymerase Chain Reaction / Q000379:methods*; D014376:Tuberculosis / Q000382:microbiology